JAM
Jupiter Asset Management’s Vertex Pharmaceuticals VRTX Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q1 | – | Sell |
-78,166
| Closed | -$31.5M | – | 508 |
|
2024
Q4 | $31.5M | Sell |
78,166
-81,761
| -51% | -$32.9M | 0.31% | 109 |
|
2024
Q3 | $74.4M | Buy |
159,927
+159,342
| +27,238% | +$74.1M | 0.65% | 33 |
|
2024
Q2 | $274K | Sell |
585
-90,194
| -99% | -$42.3M | ﹤0.01% | 373 |
|
2024
Q1 | $37.9M | Sell |
90,779
-72,637
| -44% | -$30.4M | 0.36% | 92 |
|
2023
Q4 | $66.5M | Buy |
163,416
+117,210
| +254% | +$47.7M | 0.66% | 34 |
|
2023
Q3 | $16.1M | Buy |
46,206
+366
| +0.8% | +$127K | 0.18% | 161 |
|
2023
Q2 | $16.1M | Sell |
45,840
-125,179
| -73% | -$44M | 0.18% | 161 |
|
2023
Q1 | $53.8M | Buy |
171,019
+40,504
| +31% | +$12.7M | 0.74% | 26 |
|
2022
Q4 | $37.7M | Buy |
130,515
+38,968
| +43% | +$11.2M | 0.55% | 48 |
|
2022
Q3 | $26.5M | Sell |
91,547
-33,485
| -27% | -$9.7M | 0.41% | 64 |
|
2022
Q2 | $35.2M | Sell |
125,032
-985
| -0.8% | -$278K | 0.5% | 55 |
|
2022
Q1 | $32.9M | Buy |
126,017
+123,034
| +4,125% | +$32.1M | 0.39% | 79 |
|
2021
Q4 | $664K | Sell |
2,983
-303,880
| -99% | -$67.6M | 0.01% | 448 |
|
2021
Q3 | $55.7M | Buy |
306,863
+260,450
| +561% | +$47.2M | 0.63% | 33 |
|
2021
Q2 | $9.36M | Buy |
+46,413
| New | +$9.36M | 0.1% | 213 |
|
2021
Q1 | – | Sell |
-53,800
| Closed | -$12.7M | – | 667 |
|
2020
Q4 | $12.7M | Buy |
53,800
+26,174
| +95% | +$6.18M | 0.13% | 194 |
|
2020
Q3 | $7.51M | Buy |
+27,626
| New | +$7.51M | 0.08% | 251 |
|